ATAI Life Sciences N.V. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ATAI Life Sciences N.V. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • ATAI Life Sciences N.V. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $90M, a 5.97% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $90M -$5.71M -5.97% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $95.7M +$46.2M +93.5% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $49.4M +$35.3M +249% Dec 31, 2021 10-K 2023-03-24
Q4 2020 $14.2M Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.